Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.25 USD | -1.75% | -8.20% | -29.25% |
May. 15 | Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA | CI |
May. 15 | Lumos Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 2.640 | 2.760 | 2.960 |
Spread/Res. | -14.77% | -18.48% | -23.99% |
Spread/Supp. | +0.45% | +0.45% | +5.14% |
Support | 2.240 | 2.240 | 2.140 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- LUMO Stock
- Charts Lumos Pharma, Inc.